Table 1.
Age-adjusted incidence rates of invasive cancers by sex, Surveillance, Epidemiology, and End Results (SEER) cancer registry 2005–2009*
| Cancer | Males | Females | Male/Female ratio |
|---|---|---|---|
| All shared sites† | 365.7 | 229.6 | 1.59 |
| Gastrointestinal tract | 105.9 | 70.6 | 1.50 |
| Colon and rectum | 54.0 | 40.2 | 1.34 |
| Pancreas | 13.8 | 10.8 | 1.28 |
| Lung and bronchus | 76.4 | 52.7 | 1.45 |
| Urinary system | 59.0 | 20.0 | 2.95 |
| Kidney and renal pelvis | 20.7 | 10.5 | 1.97 |
| Bladder | 37.0 | 8.9 | 4.16 |
| Melanoma | 27.2 | 16.7 | 1.63 |
| Thyroid | 5.9 | 17.3 | 0.34 |
| Hematologic malignancies | 50.4 | 33.3 | 1.51 |
* Rates are given per 100 000 persons and are age-adjusted to the 2000 US standard population (19 age groups; Census P25-1130) from 18 SEER areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California [excluding San Francisco/San Jose-Monterey/Los Angeles], Kentucky, Louisiana, New Jersey, and Georgia [excluding Atlanta/Rural Georgia]) (1).
† Includes cancer of the oral cavity and pharynx, digestive system, respiratory system, bones and joints, soft tissue, urinary system, eye and orbit, brain and nervous system, and endocrine system, as well as melanoma of the skin, hematologic malignancies, Kaposi sarcoma, and mesothelioma; does not include ill-defined and unspecified cancers.